Meeting
2019 ASCO Annual Meeting
The Circulating Cell-free Genome Atlas (CCGA) Study: Follow-up (F/U) on non-cancer participants with cancer-like cell-free DNA signals.
Authors
Allen Lee Cohn
Rocky Mountain Cancer Center, US Oncology, Denver, CO
Allen Lee Cohn , Michael Seiden , Kathryn N. Kurtzman , Earl Hubbell , Samuel Gross , Oliver Venn , Eric T. Fung , Minetta C. Liu , Eric A. Klein , Geoffrey R. Oxnard , Anne-Renee Hartman , David Michael Waterhouse
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Clinical Trial Registration Number
NCT02889978
Citation
J Clin Oncol 37, 2019 (suppl; abstr 5574)
DOI
10.1200/JCO.2019.37.15_suppl.5574
Abstract #
5574
Poster Bd #
397
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Detection of cancer signal for over 50 AJCC cancer types with a multi-cancer early-detection test.
First Author: Habte Aragaw Yimer
Poster
2020 ASCO Virtual Scientific Program
Tumor methylation patterns to measure tumor fraction in cell-free DNA.
First Author: Colin Melton
Poster
2019 ASCO Annual Meeting
The Circulating Cell-free Genome Atlas (CCGA) Study: Size selection of cell-free DNA (cfDNA) fragments.
First Author: Darya Filippova
Poster
2023 ASCO Annual Meeting
Changes in ctDNA levels as an early indicator of outcomes in advanced NSCLC treated with TKI: Initial findings from a retrospective aggregate analysis of 8 clinical trials.
First Author: Hillary Stires